Time to go for vivax
Edited by: Marcus V Lacerda and Hernando A del Portillo
Housing and malaria
Edited by: Dr. Lucy Tusting, Dr. Jo Lines and Barbary Willey
Re-imagining malaria – a platform for reflections to widen horizons in malaria control
Edited by: Dr. Julian Eckl, Dr. Susanna Hausmann Muela
Cross journal collection
Every day is Malaria Day
Cross journal collection
Reviewer acknowledgements 2013
WHO global malaria recommendations 2012 - 2015
Edited by: Prof Patricia Schlagenhauf
National malaria control programme (NMCP) Best Practice Sharing
Edited by: Prof Robert William Snow
Towards malaria elimination
The world antimalarial resistance network (WARN)
Aims and Scope
Malaria Journal is aimed at the scientific community interested in malaria in its broadest sense. It is the only journal that publishes exclusively articles on malaria and, as such, it aims to bring together knowledge from the different specialties involved in this very broad discipline, from the bench to the bedside and to the field. Malaria Journal offers a fast publication schedule while maintaining rigorous peer-review; this is achieved by managing the whole of the publication process electronically, from submission to peer-review.
Editor-in-Chief - Marcel Hommel, University of Liverpool, UK
27 April 2018
25 April 2018
In 2002, the vivax malaria community created a forum for providing a friendly environment to share and discuss research results on Plasmodium vivax. Meetings were held in Bangkok, Rockville, Panama, Barcelona, Bali, and this year, in Manaus.
The aim of this Thematic series, ‘Time to go for vivax’ (the motto of the Manaus meeting) is to emphasize this biennial event and the role it plays in promoting the study of Plasmodium vivax. The articles in the series are all based on presentations given in Manaus.
Guest editors: Marcus V Lacerda and Hernando A del Portillo
ACTwatch report on their 10-year monitoring of ACT usage in sub-Saharan Africa and in the Greater Mekong sub- region, make recommendations and share their data with the malaria community. They have spoken to BugBitten about their work and their motivation for making their datasets publicly available.
Ivermectin has been used to treat some NTDs for years, but its potential use to block malaria transmission is not well known. Carlos Chaccour and colleagues review the role the ivermectin can play in reducing malaria. Carlos Chaccour and Regina Rabinovich also discuss the series and ivermectin in their interview with BugBitten blog.
2016 Journal Metrics
50 days from submission to first decision
13 days from acceptance to publication
1553.0 Usage Factor
Social Media Impact